Last updated on

Pancreas
Research Hotspot & Journal Scope - Therapy


Pancreas - DOI: 10.1097/MPA.0000000000001231
Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis

Jordan M Cloyd · Hsiang-Chun Chen · Xuemei Wang · Ching-Wei D Tzeng · Michael P Kim · Thomas A Aloia · Jean-Nicolas Vauthey · Jeffrey E Lee · Matthew H G Katz ·

Medicine
PDF
Pancreas - DOI: 10.1097/MPA.0000000000001271
Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases

Daniel H Kwon · Alan Paciorek · Claire K Mulvey · Hilary Chan · Nicholas Fidelman · Lingzhong Meng · Eric K Nakakura · Li Zhang · Emily K Bergsland · Katherine Van Loon ·

Medicine
PDF
Pancreas - DOI: 10.1097/MPA.0000000000001373
Time to Adjuvant Systemic Therapy Following Pancreatic Cancer Resection and Effect on Outcome

Richard J White · Shaakir Hasan · Dulabh Monga · Gene Finley · Mohammed Islam · Suzanne Schiffman · H Kenneth Williams · Abhijit Kulkarni · Shyam Thakkar · Alexander V Kirichenko · Rodney E Wegner ·

Medicine
PDF
Pancreas - DOI: 10.1097/MPA.0000000000001398
Combined Antiangiogenic Therapy and Immunotherapy Is Effective for Pancreatic Cancer With Mismatch Repair Proficiency but High Tumor Mutation Burden

Mengni Chen · Shengli Yang · Li Fan · Lu Wu · Renwang Chen · Jian Chang · Jianli Hu ·

Medicine
PDF
Pancreas - DOI: 10.1097/MPA.0000000000001433
Reducing Pancreatic Fibrosis Using Antioxidant Therapy Targeting Nrf2 Antioxidant Pathway

Greg Garo Kojayan · Reza Fazl Alizadeh · Shiri Li · Hirohito Ichii ·

Medicine
PDF

According to the NICE scope, pembrolizumab was compared with single or combination chemotherapy.

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal [10.1007/s40273-019-00792-7]


Conclusion: The identified hub genes facilitate our knowledge of the underlying molecular mechanism of how Treg cells affect ccRCC in anti-tumor immune therapy.

Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis [10.18632/aging.102397]


Initial treatment was adequate irrigation and debridement, bone-void filling with bioactive glass, external fixation and provisional negative pressure wound therapy (NPWT).

The use of bioactive glass S53P4 in the treatment of an infected Charcot foot: a case report. [10.12968/jowc.2019.28.Sup1.S14]


We used the National Cancer Database (NCDB) to investigate the utilization and effectiveness of high-dose thoracic radiotherapy (RT) with systemic therapy (ST), compared to low-dose RT with ST, or ST alone in patients with metastatic non-small cell lung cancer (mNSCLC), hypothesizing that the use of high-dose thoracic RT with ST would increase in time and be associated with improved overall survival (OS).

The utilization patterns and comparative effectiveness of systemic therapy with high-dose thoracic radiotherapy or low-dose thoracic radiotherapy versus systemic therapy alone in newly diagnosed metastatic non-small cell lung cancer patients [10.1007/s13566-020-00414-2]


Ninety patients had received radiation (EBRT: 47, IMRT: 14, proton beam: 3, brachytherapy: 22, EBRT+brachy: 14) and 31 had received focal therapy (cryotherapy: 18, HIFU: 9, microwave/electroporation: 4) as primary treatment.

V11-01 SALVAGE ROBOT-ASSISTED LAPAROSCOPIC PROSTATECTOMY: DOES PRIMARY TREATMENT MAKE A DIFFERENCE? [10.1097/01.JU.0000557382.22918.66]


Highly Related Keywords from Therapy

Research Hotspot

Pancreas

Research Hotspot
Pancreas Related Journals

Popular Journals